Precise, accurate imaging – think mammography, CT and MRI scans – is important to cancer screening, treatment, and follow-up care. Now, even more advanced technology is emerging, and with it, the need for imaging specialists with the expertise to use them.
Huntsman Cancer Institute at the University of Utah has demonstrated particular excellence in the field, as demonstrated by the establishment of the National Cancer Institute for Quantitative Imaging Excellence.
According to NCI, the program was necessary to establish standard operating procedures and guidelines for the new technology that would be uniform across the entire network of cancer facilities. Once a center has earned this certification, it is deemed trial ready and capable of conducting NCI-sponsored clinical trials that use advanced quantitative imaging. Before, there were significant delays in the time required to open a clinical trial when the advanced imaging technology was needed.
“As Huntsman Cancer Institute works to provide new approaches to individualized cancer diagnosis and therapy through clinical trials, the ability to provide our patients with cutting edge technology and highly trained specialists is becoming more and more important.” – ?Mary Beckerle HCI CEO and director
Beckerle credits John M. Hoffman, M.D., co-leader of HCI’s Imaging, Diagnostics, and Therapeutics Research Program and a professor of radiology and neurology at the University of Utah, for his work to obtain the NCI credential.
